Fortive (FTV) AI Stock Analysis

• Market Cap: $16.45B
• Dividend Yield: 0.51%
• Average Volume (3M): 4.13M
• Price to Earnings (P/E): 21.9
• Beta (1Y): 1.03
• Revenue Growth: -0.12%
• EPS Growth: -11.27%
• Country: US
• Employees: 18,000
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): 0.68
• Shares Outstanding: 338,336,330
• 10 Day Avg. Volume: 4,599,565
• 30 Day Avg. Volume: 4,133,776
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.67
• Enterprise Value/Revenue: 4.47
• Enterprise Value/Gross Profit: 7.47
• Enterprise Value/Ebitda: 17.40
• 1Y Price Target: $56.54
• Price Target Upside: 16.27% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 14

• Rating: 75 Outperform
• Price Target: $55.00 ▲(13.10% Upside)

Fortive's overall stock score reflects strong financial performance and strategic resilience, despite facing revenue and cost pressures. The company's robust cash flow and strategic initiatives, such as the Ralliant spin-off, support a positive outlook. However, technical indicators and valuation suggest caution, with potential resistance and moderate valuation levels.

Positive Factors

Cash Flow Generation

Fortive's strong cash flow generation indicates efficient capital management and provides the company with flexibility for strategic investments and debt management.

Strategic Initiatives

The successful spin-off of Ralliant demonstrates Fortive's ability to execute strategic initiatives, potentially enhancing focus and operational efficiency in its core segments.

Recurring Revenue Growth

Growth in recurring revenues provides Fortive with a stable and predictable income stream, supporting long-term financial stability and reducing reliance on one-time sales.

Negative Factors

Revenue Decline

A decline in revenue indicates challenges in maintaining sales growth, potentially impacting profitability and market position if not addressed.

Tariff Impacts

Tariff-related cost pressures can erode margins and increase operational costs, affecting Fortive's competitive pricing and profitability in affected markets.

Healthcare Segment Challenges

Revenue decline in the healthcare segment due to policy changes and spending deferrals could hinder growth in a key market, requiring strategic adjustments.

Fortive Business Overview & Revenue Model

Company Description

Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

How the Company Makes Money

Fortive generates revenue primarily through the sale of its diverse range of products and services in its core segments: Professional Instrumentation and Industrial Technologies. The company earns money by selling high-precision instruments, software, and automation solutions that are essential for various industrial applications. Key revenue streams include product sales, recurring software subscription fees, and service contracts for maintenance and support. Additionally, Fortive benefits from partnerships with other technology firms and collaborations with industry leaders that enhance its product offerings and market reach. The company's focus on innovation and efficiency, along with its strategic acquisitions, further contribute to its revenue growth.

Fortive Financial Statement Overview

Summary

Fortive demonstrates strong financial performance with consistent revenue growth and robust cash flow generation. The company maintains a stable balance sheet with manageable leverage and efficient equity usage. Minor fluctuations in profit margins and a slight increase in debt are present, but overall, the trajectory remains positive.

Income Statement

Fortive has demonstrated strong revenue growth with a notable increase from $5.25 billion in 2021 to $6.15 billion in TTM (Trailing-Twelve-Months) 2025. The gross profit margin remains robust at 59.8% for TTM 2025, indicating effective cost management. However, the net profit margin decreased slightly to 12.5% in TTM 2025, suggesting some pressure on net earnings. Despite these challenges, EBIT and EBITDA margins are healthy, reflecting solid operational efficiency.

Balance Sheet

The debt-to-equity ratio in TTM 2025 is approximately 0.46, reflecting a stable leverage position. Return on equity (ROE) is healthy at 7.41%, indicating efficient use of equity. The equity ratio stands strong at 56.9%, highlighting a solid equity base. Overall, the balance sheet shows stability, although there's a slight increase in total debt over the years, which should be monitored.

Cash Flow

Fortive's cash flow performance is strong, with operating cash flow to net income ratio at 1.97 in TTM 2025, indicating strong cash generation relative to net income. The free cash flow to net income ratio is robust at 1.80, reflecting efficient capital expenditure management. While free cash flow growth is relatively stable, it shows a slight decrease compared to previous years, which could impact future investments.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.15B	6.23B	6.07B	5.83B	5.25B	4.63B
Gross Profit	3.68B	3.73B	3.59B	3.36B	3.01B	2.62B
EBITDA	1.58B	1.67B	1.57B	1.44B	1.18B	2.04B
Net Income	768.90M	832.90M	865.80M	755.20M	608.40M	1.61B
Balance Sheet
Total Assets	18.24B	17.02B	16.91B	15.89B	16.47B	16.05B
Cash, Cash Equivalents and Short-Term Investments	1.83B	813.30M	1.89B	709.20M	819.30M	2.94B
Total Debt	4.81B	3.88B	3.81B	3.42B	4.14B	4.43B
Total Liabilities	7.86B	6.82B	6.59B	6.20B	6.95B	7.08B
Stockholders Equity	10.38B	10.19B	10.32B	9.68B	9.51B	8.96B
Cash Flow
Free Cash Flow	1.39B	1.41B	1.25B	1.21B	911.10M	1.36B
Operating Cash Flow	1.51B	1.53B	1.35B	1.30B	961.10M	1.44B
Investing Cash Flow	-64.60M	-1.80B	-195.40M	-102.50M	-2.62B	-148.40M
Financing Cash Flow	-268.30M	-792.70M	32.30M	-1.27B	652.00M	-696.10M

Fortive Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 48.63
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FTV, the sentiment is Positive. The current price of 48.63 is above the 20-day moving average (MA) of 48.22, below the 50-day MA of 48.81, and below the 200-day MA of 53.85, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 51.45 is Neutral, neither overbought nor oversold. The STOCH value of 54.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FTV.

Fortive Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SANM	80 Outperform	6.30B	25.33	10.13%	―	5.87%	20.66%
TDY	79 Outperform	26.51B	31.15	8.28%	―	6.47%	-1.48%
FTV	75 Outperform	$16.45B	21.95	7.36%	0.51%	-0.12%	-11.27%
FLEX	74 Outperform	22.01B	25.76	17.51%	―	-3.63%	2.26%
TRMB	69 Neutral	19.70B	70.69	26.18%	―	-3.72%	-80.83%
COHR	60 Neutral	17.00B	-205.13	0.61%	―	23.42%	71.17%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%